Annual Revenue
$2.35 B
+$117.34 M+5.24%
31 December 2023
Summary:
Royalty Pharma annual revenue is currently $2.35 billion, with the most recent change of +$117.34 million (+5.24%) on 31 December 2023. During the last 3 years, it has risen by +$232.20 million (+10.94%). RPRX annual revenue is now at all-time high.RPRX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$564.69 M
+$27.42 M+5.10%
30 September 2024
Summary:
Royalty Pharma quarterly revenue is currently $564.69 million, with the most recent change of +$27.42 million (+5.10%) on 30 September 2024. Over the past year, it has increased by +$28.38 million (+5.29%). RPRX quarterly revenue is now -17.44% below its all-time high of $683.97 million, reached on 31 March 2023.RPRX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$2.27 B
+$28.38 M+1.27%
30 September 2024
Summary:
Royalty Pharma TTM revenue is currently $2.27 billion, with the most recent change of +$28.38 million (+1.27%) on 30 September 2024. Over the past year, it has dropped by -$58.23 million (-2.51%). RPRX TTM revenue is now -4.04% below its all-time high of $2.36 billion, reached on 30 June 2023.RPRX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPRX Revenue Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +5.2% | +5.3% | -2.5% |
3 y3 years | +10.9% | -3.6% | -0.9% |
5 y5 years | +31.2% | +21.6% | +67.0% |
RPRX Revenue High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +10.9% | -17.4% | +5.4% | -4.0% | +1.3% |
5 y | 5 years | at high | +31.2% | -17.4% | +23.4% | -4.0% | +67.0% |
alltime | all time | at high | +47.4% | -17.4% | +29.9% | -4.0% | +421.1% |
Royalty Pharma Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $564.69 M(+5.1%) | $2.27 B(+1.3%) |
June 2024 | - | $537.27 M(-5.4%) | $2.24 B(-0.0%) |
Mar 2024 | - | $567.98 M(-4.7%) | $2.24 B(-4.9%) |
Dec 2023 | $2.35 B(+5.2%) | $596.07 M(+11.1%) | $2.35 B(+1.3%) |
Sept 2023 | - | $536.31 M(-0.4%) | $2.32 B(-1.6%) |
June 2023 | - | $538.20 M(-21.3%) | $2.36 B(+0.1%) |
Mar 2023 | - | $683.97 M(+20.9%) | $2.36 B(+5.4%) |
Dec 2022 | $2.24 B(-2.3%) | $565.75 M(-1.3%) | $2.24 B(-0.4%) |
Sept 2022 | - | $573.46 M(+7.0%) | $2.25 B(-0.5%) |
June 2022 | - | $535.96 M(-4.6%) | $2.26 B(-0.8%) |
Mar 2022 | - | $562.05 M(-2.4%) | $2.28 B(-0.5%) |
Dec 2021 | $2.29 B | $575.70 M(-1.7%) | $2.29 B(+0.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2021 | - | $585.77 M(+5.6%) | $2.29 B(+2.1%) |
June 2021 | - | $554.96 M(-3.2%) | $2.24 B(+2.0%) |
Mar 2021 | - | $573.03 M(+0.2%) | $2.19 B(+3.4%) |
Dec 2020 | $2.12 B(+17.0%) | $572.14 M(+6.3%) | $2.12 B(+5.7%) |
Sept 2020 | - | $538.40 M(+5.4%) | $2.01 B(+3.8%) |
June 2020 | - | $510.93 M(+2.0%) | $1.93 B(+2.8%) |
Mar 2020 | - | $500.88 M(+9.5%) | $1.88 B(+3.6%) |
Dec 2019 | $1.81 B(+1.1%) | $457.49 M(-1.5%) | $1.81 B(+33.7%) |
Sept 2019 | - | $464.28 M(+1.5%) | $1.36 B(+52.0%) |
June 2019 | - | $457.61 M(+5.2%) | $892.49 M(+105.2%) |
Mar 2019 | - | $434.88 M | $434.88 M |
Dec 2018 | $1.79 B(+12.3%) | - | - |
Dec 2017 | $1.60 B | - | - |
FAQ
- What is Royalty Pharma annual revenue?
- What is the all time high annual revenue for Royalty Pharma?
- What is Royalty Pharma annual revenue year-on-year change?
- What is Royalty Pharma quarterly revenue?
- What is the all time high quarterly revenue for Royalty Pharma?
- What is Royalty Pharma quarterly revenue year-on-year change?
- What is Royalty Pharma TTM revenue?
- What is the all time high TTM revenue for Royalty Pharma?
- What is Royalty Pharma TTM revenue year-on-year change?
What is Royalty Pharma annual revenue?
The current annual revenue of RPRX is $2.35 B
What is the all time high annual revenue for Royalty Pharma?
Royalty Pharma all-time high annual revenue is $2.35 B
What is Royalty Pharma annual revenue year-on-year change?
Over the past year, RPRX annual revenue has changed by +$117.34 M (+5.24%)
What is Royalty Pharma quarterly revenue?
The current quarterly revenue of RPRX is $564.69 M
What is the all time high quarterly revenue for Royalty Pharma?
Royalty Pharma all-time high quarterly revenue is $683.97 M
What is Royalty Pharma quarterly revenue year-on-year change?
Over the past year, RPRX quarterly revenue has changed by +$28.38 M (+5.29%)
What is Royalty Pharma TTM revenue?
The current TTM revenue of RPRX is $2.27 B
What is the all time high TTM revenue for Royalty Pharma?
Royalty Pharma all-time high TTM revenue is $2.36 B
What is Royalty Pharma TTM revenue year-on-year change?
Over the past year, RPRX TTM revenue has changed by -$58.23 M (-2.51%)